The goal of this clinical trial is to improve the frailty in old patients who have a cardiac disease . Researchers will determine the improvement in the instability and the strength along twelve sessions based on guided exercises and mobility techniques made by physiotherapists. Research team will also evaluate the medications and diet, as well as laboratory and clinical tests.
Intitial visit to measure quality of life, instability and strenght, followed by twelve sessions, one each week will be performed
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
PREVENTION
Masking
NONE
Enrollment
60
Primary care based physiotherapy groups
Primary Care Centers
Barcelona, Select..., Spain
Short Physical Performance Battery (SPPB) components (balance, gait speed, chair rise)
Improvement in baseline values: each of the three component scores \<= 4 points, and tests consists of: balance test, Gait speed and chair-stand tests. Maximum possible is 12 points and under 10 points means frailty
Time frame: From enrollment to the end of treatment ending after 12 weeks.
Euroqol5D Goldberg Anxiety and Depression Scale Number of falls throughout the study Major Cardiovascular events Adherence to the program
Euroqol5D measures the Quality of life through an Analogic Visual Scale, which ranks from 0 (worst) to100(best) Goldberg anxiety and depression scales measure the probabilty of suffering from anxiety or depression. The tests consist in a total of 9 questions for each dimension. A score of \>=4 in any of the dimensions suggest pathology. Adherence to the program will be evbaluated counting the attendance to the sessions. More than 9 sessions will be considerated good adherence
Time frame: from the baseline to 12 weeks of intervention
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.